What Is Waldenström Macroglobulinemia? Symptoms, Diagnosis, and Treatment
The blood contains different types of cells that perform important functions, such as carrying oxygen, fighting infections, and helping the body control bleeding. Sometimes, abnormal changes in certain white blood cells can lead to a rare type of blood cancer called Waldenström macroglobulinemia.
This condition affects the bone marrow, where blood cells are produced. It causes abnormal cells to multiply and produce excessive amounts of a protein called immunoglobulin M, or IgM. As this protein builds up in the blood, it can make the blood thicker and interfere with normal circulation.
What Is Waldenström Macroglobulinemia?
Waldenström macroglobulinemia is a rare type of non-Hodgkin lymphoma. It develops from abnormal B lymphocytes, which are white blood cells that normally help the immune system fight infections.
These abnormal cells grow mainly in the bone marrow and produce large amounts of IgM antibodies. Unlike normal antibodies, the excess IgM protein can accumulate in the bloodstream and cause a condition called hyperviscosity, in which the blood becomes unusually thick.
Waldenström macroglobulinemia is also known as lymphoplasmacytic lymphoma when it involves the typical combination of lymphocytes and plasma-cell-like cells.
What Causes Waldenström Macroglobulinemia?
The exact cause of Waldenström macroglobulinemia is not fully understood. It develops when genetic changes affect B lymphocytes and cause them to grow abnormally.
Researchers have identified certain genetic changes associated with this disease.
MYD88 mutation: Many patients have a genetic change called MYD88 L265P. It can influence signals that encourage abnormal cells to survive and multiply.
CXCR4 mutations: Some patients have changes in the CXCR4 gene, which may affect disease behavior and response to certain treatments.
Family history: Having a close relative with Waldenström macroglobulinemia or another related blood disorder may increase the risk, although the disease is not usually inherited directly.
Older age is another important risk factor. The condition is more commonly diagnosed in older adults and is somewhat more frequent in men.
Having a risk factor does not mean someone will develop the disease.
What Are the Symptoms of Waldenström Macroglobulinemia?
Symptoms may develop slowly because the abnormal cells often grow over a long period. Some people have no noticeable symptoms when the disease is first discovered.
Common symptoms include:
Unusual tiredness: Anemia can develop when abnormal cells interfere with normal blood cell production.
Weakness and dizziness: Reduced oxygen-carrying capacity or changes in blood circulation may cause these problems.
Frequent infections: Abnormal immune function can make it harder for the body to fight certain infections.
Easy bruising or bleeding: Low platelet levels or other blood-related changes may increase bleeding.
Vision problems: Thickened blood can affect small blood vessels and cause blurred vision or other visual changes.
Headaches: Increased blood thickness may interfere with normal circulation.
Numbness or tingling: Some patients experience nerve problems, particularly in the hands and feet.
Enlarged lymph nodes: Lymph nodes may become swollen in some cases.
Night sweats and weight loss: Some people experience these general symptoms associated with lymphoma.
Severe hyperviscosity can cause serious complications, including changes in vision, confusion, or neurological symptoms. Sudden or severe symptoms require urgent medical attention.
How Does Waldenström Macroglobulinemia Affect the Body?
The disease can affect different parts of the body in several ways.
Increased Blood Thickness
Excess IgM protein can make blood more viscous. This may slow circulation and interfere with the delivery of oxygen to tissues.
Reduced Blood Cell Production
Abnormal cells can take up space in the bone marrow, affecting the production of healthy red blood cells, white blood cells, and platelets.
Nerve Problems
Some IgM proteins can interact with components of the nervous system. This may contribute to peripheral neuropathy, which can cause numbness, tingling, or weakness.
Organ Enlargement
In some patients, abnormal cells accumulate in the spleen, liver, or lymph nodes, causing these structures to become enlarged.
How Is Waldenström Macroglobulinemia Diagnosed?
Doctors use blood tests, bone marrow examinations, and genetic testing to confirm the condition and understand its characteristics.
Blood Tests
A complete blood count helps identify anemia and changes in white blood cell or platelet levels.
Doctors may also measure IgM levels and examine other blood proteins. A serum protein electrophoresis test and immunofixation can help identify abnormal monoclonal IgM protein.
Bone Marrow Biopsy
A bone marrow biopsy is an important part of diagnosis. A small sample of bone marrow is collected, usually from the hip bone, and examined under a microscope.
The test helps identify abnormal lymphoplasmacytic cells and determine how much of the bone marrow is affected.
Genetic Testing
Laboratory tests may look for MYD88 and CXCR4 mutations. These findings can help confirm the diagnosis and provide information that may influence treatment decisions.
Imaging Tests
CT scans or other imaging tests may be recommended when doctors need to check for enlarged lymph nodes, spleen enlargement, or other areas affected by the disease.
What Are the Treatment Options for Waldenström Macroglobulinemia?
Not everyone diagnosed with Waldenström macroglobulinemia needs immediate treatment. People without symptoms or serious complications may be monitored regularly.
When treatment becomes necessary, doctors consider the patient's symptoms, blood counts, IgM levels, disease activity, and overall health.
Targeted Therapy
Targeted medicines act on specific proteins or signals involved in abnormal cell growth.
Bruton tyrosine kinase inhibitors, such as ibrutinib and zanubrutinib, are used for certain patients. They block signals that help abnormal B cells survive.
Immunotherapy
Medicines such as rituximab target the CD20 protein found on many B cells. They may be used alone or in combination with other treatments.
Chemotherapy
Chemotherapy medicines destroy or slow the growth of abnormal cells. They may be combined with immunotherapy depending on the patient's condition and treatment plan.
Plasma Exchange
Plasma exchange, also called plasmapheresis, may be used when excessive IgM causes severe hyperviscosity.
During this procedure, the liquid part of the blood containing excess protein is removed and replaced. It can provide rapid relief from dangerous blood thickening, but it does not eliminate the abnormal cells causing the disease.
Regular Monitoring
Patients who do not have symptoms requiring treatment may undergo regular blood tests and medical examinations. This approach is often called active surveillance or watchful waiting.
FAQs
Is Waldenström macroglobulinemia a type of blood cancer?
Yes. It is a rare type of non-Hodgkin lymphoma that affects B lymphocytes and causes excessive production of IgM antibodies.
Is Waldenström macroglobulinemia curable?
It is generally considered a chronic disease rather than a curable condition. However, several treatments can control it, reduce symptoms, and help patients live longer.
Does Waldenström macroglobulinemia spread quickly?
Usually, it grows slowly. However, its behavior and effects vary, and some patients may develop complications that require treatment.
Can someone have Waldenström macroglobulinemia without symptoms?
Yes. Some people are diagnosed through routine blood tests before experiencing noticeable symptoms. They may only need regular monitoring initially.
Conclusion
Waldenström macroglobulinemia is a rare blood cancer that develops from abnormal B lymphocytes in the bone marrow. It causes excessive production of IgM protein, which can make the blood thicker and interfere with normal blood cell production and circulation.
Symptoms may include fatigue, weakness, frequent infections, vision changes, nerve problems, and unusual bleeding. Blood tests, bone marrow biopsy, and genetic testing help doctors confirm the diagnosis.
